Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001796280-25-000001
Filing Date
2025-06-06
Accepted
2025-06-06 12:22:24
Documents
1
Effectiveness Date
2025-06-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11007
  Complete submission text file 0001796280-25-000001.txt   12206
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-548268 | Film No.: 251029664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)